Effect of Combination Montelukast and Nasal Mometasone on Childhood Adenoid Hypertrophy

Document Type : Original

Authors

1 Division of Infectious Diseases, Department of Pediatrics, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran.

2 Department of Pediatrics, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran.

3 Pediatric Gastroenterology and Hepatology Research Center, Division of Gastroenterology, Department of Pediatric, Bahrami Children Hospital, Tehran University of Medical Sciences, Tehran, Iran.

4 Division of Gastroenterology, Department of Pediatrics, Bahrami Children Hospital, Tehran University of Medical Sciences, Tehran, Iran.

5 Division of Allergy and Clinical Immunology, Department of Pediatrics, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran.

10.22038/ijorl.2024.73906.3490

Abstract

Introduction: Adenoid hypertrophy is a common childhood disease; its standard treatment is adenoidectomy. The desire for medical management is increasing due to fewer complications and more convenience. The present study investigated the effect of adding oral montelukast to mometasone nasal spray in treating adenoid hypertrophy.
Materials and Methods: This was a randomized, double-blind, placebo-controlled study conducted at a referral teaching hospital (Tehran, Iran) from September 2020 to September 2021. Children aged 2 to 14 years with clinical and radiological findings of adenoid hypertrophy were enrolled. Patients were randomly divided into two groups: mometasone nasal spray with oral montelukast (case group) or mometasone with placebo (control group). Then, the clinical scores were compared before and two months after the intervention.
Results: Ninety-six patients completed the study [62.5% male (n=60)]. Of these, 51 were in the case and 45 in the control group. The clinical score in each group decreased significantly after the intervention (P<0.001), but the decrease in clinical score in the case group was not significantly different from the control (p=0.576).
Conclusion: The results showed that the combination therapy with mometasone and montelukast has the same efficacy as mometasone and placebo in treating adenoid hypertrophy. Adding montelukast to mometasone has no additional effect.

Keywords

Main Subjects

References

  1. Goeringer GC, Vidić B. The embryogenesis and anatomy of Waldeyer's ring. Otolaryngol Clin North Am. 1987 May;20(2):207-17. PMID: 3601384.
  2.  Hellings P, Jorissen M, Ceuppens JL. The Waldeyer's ring. Acta Otorhinolaryngol Belg. 2000; 54(3):237-41. PMID: 11082757.
  3.  Marseglia G, Caimmi D, Pagella F, Matti E, Labò E, Licari A, et al.. Adenoids during childhood: the facts. Int J Immunopathol Pharmacol. 2011 Oct;24(4 Suppl):1-5. doi: 10.1177/03946320110240 S401. PMID: 22032778.
  4.  Vogler RC, Ii FJ, Pilgram TK. Age-specific size of the normal adenoid pad on magnetic resonance imaging. Clin Otolaryngol Allied Sci. 2000 Oct;25(5):392-5. doi: 10.1046/j.1365-2273.2000. 00381.x. PMID: 11012653.
  5.  Pereira L, Monyror J, Almeida FT, Almeida FR, Guerra E, Flores-Mir C, Pachêco-Pereira C. Prevalence of adenoid hypertrophy: A systematic review and meta-analysis. Sleep Med Rev. 2018 Apr;38:101-112. doi: 10.1016/j.smrv.2017.06.001.
  6.  Shokouhi F, Meymaneh Jahromi A, Majidi MR, Salehi M. Montelukast in Adenoid Hypertrophy: Its Effect on Size and Symptoms. Iran J Otorhinolaryngol. 2015 Nov;27(83):443-8. PMID: 26788489; PMCID: PMC4706629.
  7. Niedzielski A, Chmielik LP, Mielnik-Niedzielska G, Kasprzyk A, Bogusławska J. Adenoid hypertrophy in children: a narrative review of pathogenesis and clinical relevance. BMJ Paediatr Open. 2023 Apr;7(1):e001710. doi: 10.1136/bmjpo-2022-001710. PMID: 37045541; PMCID: PMC10106074.
  8.  Bemanian MH, Rezaei K, Atighechi S, Shafiei A. The Relation of Allergy to Adenoid Hypertrophy and Otitis Media with Effusion: A Cross-sectional Study. Iran J Allergy Asthma Immunol. 2020 Oct 18;19(5):529-533. doi: 10.18502/ijaai.v19i5.4469. PMID: 33463120.
  9. Saedi B, Sadeghi M, Mojtahed M, Mahboubi H. Diagnostic efficacy of different methods in the assessment of adenoid hypertrophy. Am J Otolaryngol. 2011 Mar-Apr;32(2):147-51. doi: 10.1016/j.amjoto.2009.11.003. Epub 2010 Apr 13. PMID: 20392530.
  10.  Alnori, H., Sulaiman, S., Mohammed, A. The Effect of Mometasone Nasal Spray and/or Montelukast on Adenoid Size. Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 2021; 22(22): 1-8. doi: 10.21608/ejentas.2021.70841.1348
  11. Chadha NK, Zhang L, Mendoza-Sassi RA, César JA. Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work? Otolaryngol Head Neck Surg. 2009 Feb;140(2):139-47. doi: 10.1016/j.otohns.2008.11.008. PMID: 19201278.
  12. Tuhanıoğlu B, Erkan SO. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data. Turk J Med Sci. 2017 Dec 19;47(6):1736-1743. doi: 10.3906/sag-1701-179. PMID: 29306232.
  13. Ras AE, Hamed MH, Abdelalim AA. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy. Am J Otolaryngol. 2020 Nov-Dec; 41(6):102723. doi: 10.1016/j.amjoto.2020.102723.
  14. Fujioka M, Young LW, Girdany BR. Radiographic evaluation of adenoidal size in children: adenoidal-nasopharyngeal ratio. AJR Am J Roentgenol. 1979 Sep;133(3):401-4. doi: 10.2214/ajr.133.3.401. PMID: 111497
  15. Bhargava R, Chakravarti A. A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion. Am J Otolaryngol. 2014 Nov-Dec; 35(6):766-70. doi: 10.1016/j.amjoto.2014.06.006. Epub 2014 Jun 20. PMID: 25151658.
  16. Chohan A, Lal A, Chohan K, Chakravarti A, Gomber S. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol. 2015 Oct;79(10):1599-608. doi: 10.1016/j.ijporl.2015.07.009. Epub 2015 Jul 13. PMID: 26235732.
  17. Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics. 2012 Sep;130(3):e575-80. doi: 10.1542/peds.2012-0310. Epub 2012 Aug 6. PMID: 22869829.
  18. Kheirandish-Gozal L, Bandla HP, Gozal D. Montelukast for Children with Obstructive Sleep Apnea: Results of a Double-Blind, Randomized, Placebo-Controlled Trial. Ann Am Thorac Soc. 2016 Oct;13(10):1736-1741. doi: 10.1513/ AnnalsA TS.201606-432OC. PMID: 27439031; PMCID: PMC6944383.
  19. Kheirandish-Gozal L, Bhattacharjee R, Bandla HPR, Gozal D. Antiinflammatory therapy outcomes for mild OSA in children. Chest. 2014 Jul; 146(1): 88-95. doi: 10.1378/chest.13-2288. PMID: 245040 96; PMCID: PMC4077412.
  20. Yang DZ, Liang J, Zhang F, Yao HB, Shu Y. Clinical effect of montelukast sodium combined with inhaled corticosteroids in the treatment of OSAS children. Medicine (Baltimore). 2017 May; 96(19):e6628. doi: 10.1097/MD. 00000000000066 28. PMID: 28489737; PMCID: PMC5428571.
  21. Liu W, Chen RJ. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Mar 5;31(5):366-368. Chinese. doi: 10.13201/j. issn. 1001-1781.2017.05.009. PMID: 29871263.
Iranian Journal of Otorhinolaryngology
Volume 36, Issue 2
March and April 2024
Pages 391-397

Files

Share

How to cite

Statistics